Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04388020 · ClinicalTrials.gov registry record · NA
Effects of Projected Peripheral Defocus on Ocular Biometrics
A NA study, sponsored by Kubota Vision.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04388020 is a NA study that has completed, run by Kubota Vision. The registered enrollment target is 12 participants.
The verdict
NCT04388020, a NA study, has completed, sponsored by Kubota Vision.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimpeded central visual tasks and a periphery that provides defocus in order to alter retinal physiology leading to myopia regulation. This study will establish the changes seen during a proof-of-concept that projected defocus in the periphery will stimulate physiological changes similar to those in the literature.
Interventions
- DEVICE Tabletop prototype of eSpecs: Active projection of defocused image in the peripheral visual field
- DEVICE Tabletop prototype of eSpecs: No Active projection of defocused image in the peripheral visual field
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-04-11 |
| Est. Completion | 2020-05-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04388020
The ClinicalTrials.gov registry entry for NCT04388020 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kubota Vision, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tabletop prototype of eSpecs: Active projection of defocused image in the peripheral visual field is the first listed.
NCT04388020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04388020 about?
NCT04388020 is a clinical study titled "Effects of Projected Peripheral Defocus on Ocular Biometrics". Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimped...
What is the current status of trial NCT04388020?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2020-04-11. Estimated completion is 2020-05-14.
What interventions are being tested in trial NCT04388020?
The interventions under investigation include: Tabletop prototype of eSpecs: Active projection of defocused image in the peripheral visual field (DEVICE), Tabletop prototype of eSpecs: No Active projection of defocused image in the peripheral visual field (DEVICE).
Who is sponsoring clinical trial NCT04388020?
This trial is sponsored by Kubota Vision, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.